Siddiqui et al.,[37] demonstrated that the increased presence of CD4+ CD25+ FOXP3− (but not CD4+ CD25+ FOXP3+) T cells was significantly associated with higher TNM stage, larger tumor size, the presence of coagulative tumor necrosis and poorer cancer-specific survival. This evidence concerns the gene CD4 and cancer.